Investing.com - United Therapeutics reported on Wednesday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
United Therapeutics announced earnings per share of $4.91 on revenue of $516M. Analysts polled by Investing.com anticipated EPS of $4.06 on revenue of $493.81M.
United Therapeutics shares are up 5% from the beginning of the year and are trading at $228.39 , down-from-52-week-high.
United Therapeutics follows other major Healthcare sector earnings this month
United Therapeutics's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.9B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar